CK
Chung Hoow Kok
Research areas: Medicine · Hematology · Acute Myeloid Leukemia Research · Chronic Myeloid Leukemia Treatments · Chronic Lymphocytic Leukemia Research
0000-0002-3181-7852
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (22)
- Immune Checkpoint Dysfunction Remodels Adaptive Immune Receptor Repertoires in CTLA-4 Insufficiency and LRBA Deficiency Save
- Dynamic Prediction of Survival Outcomes in Multiple Myeloma Save
- Infection risk in myelodysplastic syndromes is dynamic and immune driven Save
- Evaluating NGS variant callers in a challenging genomic context with a focus on the PRSS1-PRSS2 locus for hereditary pancreatitis Save
- Direct measurement of in vivo BCR::ABL1 kinase inhibition reveals stronger potency of asciminib as compared with imatinib and nilotinib Save
- Elevated desmoglein‐2 expression in multiple myeloma is a prognostic marker across genomic subtypes with impact on high‐risk cytogenetics and a distinct gene expression profile Save
- Caspase-2 deficiency drives pathogenic liver polyploidy and increases age-associated hepatocellular carcinoma in mice Save
- RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm Save
- Substantially improved survival for intermediate-risk AML: an Australian statewide network experience spanning 20 years Save
- CD302 predicts achievement of deep molecular response in patients with chronic myeloid leukemia treated with imatinib Save
- Special Issue “Advances in Molecular Pathogenesis and Targeted Therapies for Myeloid Neoplasms” Save
- Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib Save
- Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon‐alpha Save
- A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data Save
- Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines Save
- A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure Save
- Highly sensitive droplet digital polymerase chain reaction for BCR::ABL1 messenger RNA identifies patients with chronic myeloid leukaemia with a low probability of achieving treatment‐free remission Save
- Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms Save
- CKLF and IL1B transcript levels at diagnosis are predictive of relapse in children with pre‐B‐cell acute lymphoblastic leukaemia Save
- Successful treatment‐free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells Save